Environmental Chemical Impact on the Host-Microbiome Interaction
Environmental Chemical Impact on the Host-Microbiome Interaction
批准号:
10641509
负责人:
Andrew Patterson
金额:
$93.15万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-13 至 2031-05-31
关键词:
AcuteAddressAffectAntibioticsBiochemistryChemical ExposureChemicalsChronicDietDiseaseDoseElderlyEnvironmentEnvironmental HealthEnvironmental Risk FactorEnzymatic BiochemistryExerciseExposure toGastrointestinal tract structureGoalsHazard IdentificationHealthHumanImmune responseImmunologyInflammatoryInflammatory Bowel DiseasesLife StyleMalignant NeoplasmsMetabolicMetabolic DiseasesMetabolismMicrobiologyOutcomePathway interactionsPhysiological ProcessesPhysiologyPoisonPositioning AttributeProbioticsRecording of previous eventsRegulationRisk AssessmentRoleSeminalSignal PathwaySmokingSocial InteractionStressTechnologyTherapeuticToxic Environmental SubstancesToxic effectToxicologyTranscriptional RegulationWorkXenobioticscollaborative environmentcommensal microbesdesigndietaryearly life exposureenvironmental chemicalenvironmental chemical exposureexperiencegut microbiotahost microbiomehost microbiotaimprovedinnovationinsightmicrobialmicrobiomemicrobiotamouse modelnovelresponsetoxicant interaction
中文摘要
项目总结/摘要
在环境健康科学和毒理学领域,
肠道微生物群在宿主对有毒化学品暴露的反应中的关键作用。已知微生物群
直接和间接影响饮食和环境化学品的毒性程度,
与多种疾病有关,包括代谢紊乱、癌症和炎性疾病。小心
通过严格的实验来确定微生物群影响环境的机制,
接触化学物质将使我们更全面地了解这些化学物质是如何破坏宿主的,
微生物群的相互作用,并将产生新的见解的关键信号通路的基础上,
干扰和不利的健康结果。重要的是,对微生物和环境化学物质的研究
可以提供关键的见解,更好地为可能对人类健康产生积极影响的风险评估提供信息。在这
R35 RIVER提案,我们计划在三个创新和互补的主题,以解决
统一的假设,即环境化学品暴露干扰宿主肠道微生物群的相互作用,
对健康有不利影响。首先,使用小鼠模型,我们将探索早期生活暴露于
环境化学品影响以后的生活健康结果(例如,急性和慢性代谢紊乱
炎症性肠病)通过宿主肠道微生物群轴的改变。第二,我们将研究如何
环境化学物质影响胃肠道的常见微生物,包括它们的
代谢活动和调节宿主生理的潜力。第三,我们将探索新的途径,
微生物群控制和宿主生理过程的影响。为了实现这些目标,我们组织了一个
多元化,协作,高度跨学科的团队,由生物化学,酶学,
免疫学、代谢、微生物学、转录调节和毒理学。帕特森实验室
在宿主肠道微生物群轴上沿着进行独特和开创性发现的历史,因此处于有利地位
凭借尖端的技术和方法,经验,创新的想法,以及开放/协作的
环境,以促进我们对宿主-肠道微生物群相互作用的理解,并帮助推动该领域的发展。
性新从翻译的角度来看,这些研究可能会导致新的保护方法,对饮食
以及通过设计新的益生元/益生菌的环境毒性。
英文摘要
PROJECT SUMMARY/ABSTRACT
There is an increasing level of appreciation in the fields of environmental health sciences and toxicology on the
critical role of the gut microbiota on the host response to toxic chemical exposure. The microbiota is known to
directly and indirectly influence the extent of toxicity of dietary and environmental chemicals, and has been
implicated in a wide-range of diseases including metabolic disorders, cancer, and inflammatory diseases. Careful
and rigorous experimentation to determine the mechanism by which the microbiota influences environmental
chemical exposure will lead to a more complete understanding of how these chemicals disrupt the host-
microbiota interaction and will generate novel insights into the key signaling pathways underlying those
perturbations and adverse health outcomes. Importantly, studies of the microbiota and environmental chemicals
may provide key insights that will better inform risk assessment that could positively impact human health. In this
R35 RIVER proposal, we plan to work across three innovative and complementary themes to address the
unifying hypothesis that environmental chemical exposure perturbs the host-gut microbiota interaction to
adversely affect health. First, using mouse models, we will explore the idea that early-life exposure to
environmental chemicals impacts later life health outcomes (e.g., metabolic disorders, acute and chronic
inflammatory bowel disorders) via alterations in the host-gut microbiota axis. Second, we will examine how
environmental chemicals impact common commensal microbes of the gastrointestinal tract including their
metabolic activities and potential to modulate host physiology. Third, we will explore new pathways involved in
microbiota control and influence of host physiologic processes. To achieve these goals, we have assembled a
diverse, collaborative, and highly interdisciplinary team consisting of experts in biochemistry, enzymology,
immunology, metabolism, microbiology, transcriptional regulation, and toxicology. The Patterson lab has a long
history of making unique and seminal discoveries along the host-gut microbiota axis and thus is well-positioned
with cutting-edge technology and approaches, experience, innovative ideas, and an open/collaborative
environment to advance our understanding of the host-gut microbiota interaction and help to move the field
forward. From a translational standpoint, these studies may lead to new protective approaches toward dietary
and environmental toxicity through design of new pre/probiotics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training Program
-
批准号:10417044
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2020
-
负责人:Andrew Patterson
-
依托单位:
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training Program
-
批准号:10626745
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2020
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10311068
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10066327
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:9906573
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10228735
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10539245
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10488612
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10671560
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10022323
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:9753729
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:9419367
-
项目类别:
-
资助金额:$15.72万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:9982685
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:10217133
-
项目类别:
-
资助金额:$34.56万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8545853
-
项目类别:
-
资助金额:$33.73万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8416524
-
项目类别:
-
资助金额:$47.86万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8914846
-
项目类别:
-
资助金额:$12.25万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8857440
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:9066662
-
项目类别:
-
资助金额:$25.78万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8687654
-
项目类别:
-
资助金额:$40.28万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
海外基金